LBF20207PG50: Difference between revisions
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
|SysName= (5Z, 13E) - (8R,11R,12R,15R) -11,15-dihydroxy-9-oxoprost-5,13-dienoic acid | |SysName= (5Z, 13E) - (8R,11R,12R,15R) -11,15-dihydroxy-9-oxoprost-5,13-dienoic acid | ||
|Common Name=&&15-epi-prostaglandin E_2 acetate, methyl ester&&(5Z, 13E) - (8R,11R,12R,15R) -11,15-dihydroxy-9-oxoprost-5,13-dienoic acid&& | |Common Name=&&15-epi-prostaglandin E_2 acetate, methyl ester&&(5Z, 13E) - (8R,11R,12R,15R) -11,15-dihydroxy-9-oxoprost-5,13-dienoic acid&& | ||
|Source=15-Epi-prostaglandin E<SUB><FONT SIZE=-1>2</FONT></SUB> and its methyl ester were isolated from Gorgonian, Plexaura homomalla.[[Reference:Light_RJ:Samuelsson_B:,Eur. J. Biochem.,1972,28,232|{{RelationTable/GetFirstAuthor|Reference:Light_RJ:Samuelsson_B:,Eur. J. Biochem.,1972,28,232}}]];> | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Revision as of 22:00, 24 November 2009
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR8048 |
| LipidMaps | LMFA03010094 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20207PG50 |
| 15-epi-prostaglandin E2acetate, methyl ester | |
|---|---|
| |
| Structural Information | |
| (5Z, 13E) - (8R,11R,12R,15R) -11,15-dihydroxy-9-oxoprost-5,13-dienoic acid | |
| |
| Formula | C20H32O5 |
| Exact Mass | 352.224974134 |
| Average Mass | 352.46508 |
| SMILES | C(CC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](CC1=O)O)CC |
| Physicochemical Information | |
| 15-Epi-prostaglandin E2 and its methyl ester were isolated from Gorgonian, Plexaura homomalla. Light_RJ et al.;> | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
